English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Genetic modification of mesenchymal stem cells (MSCs) with plasmid encoding the bone morphogenetic protein 2 gene ( BMP2 ) is a crucial task in the development of gene therapy and tissue engineering technologies for bone regeneration. The low transfection efficiency of MSC cultures is a limitation for practical applications and makes it necessary to search for optimal protocols that ensure efficient gene delivery while maintaining sufficient cell viability. Comparison of two transfecting reagents (TurboFect and Polyethylenimine) shows that TurboFect is the most effective for MSCs transfection. A higher level of target gene  BMP2  expression and osteogenic differentiation can be achieved using the TaqRFP-N-BMP2 plasmid compared with pcDNA3-BMP2.

Comparative study of BMP-2 gene delivery to Human adipose tissue-derived mesenchymal stem cells with Turbofect and Polyethylenimine